Invention Grant
- Patent Title: Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer
- Patent Title (中): 使用天冬氨酸腺苷制备用于治疗肝癌的药物产品
-
Application No.: US12676953Application Date: 2008-08-21
-
Publication No.: US08507459B2Publication Date: 2013-08-13
- Inventor: Victoria-Eugenia Chagoya-Hazas , Rolando-Efraín Hernandez Muñoz , Saúl Villa-Treviño
- Applicant: Victoria-Eugenia Chagoya-Hazas , Rolando-Efraín Hernandez Muñoz , Saúl Villa-Treviño
- Applicant Address: MX Ciudad Universidad
- Assignee: Universidad Nacional Autonnoma de Mexico
- Current Assignee: Universidad Nacional Autonnoma de Mexico
- Current Assignee Address: MX Ciudad Universidad
- Agency: Browdy and Neimark, P.L.L.C.
- Priority: MEMX/a/2007/010896 20070906
- International Application: PCT/MX2008/000111 WO 20080821
- International Announcement: WO2009/031876 WO 20090312
- Main IPC: A61K31/70
- IPC: A61K31/70 ; A61K31/205 ; A01N37/30
Abstract:
The present invention relates to the novel use of an adenosine aspartate product for the formulation of a drug intended to prevent the development of preneoplastic lesions and to reverse some types of cancer, particularly liver cancer, providing chemoprotection, preventing myelotoxic effects.
Public/Granted literature
Information query
